Table 4.

Comparison of repeat biopsy and final RRP pathology

	Repeat biopsy		Final prostate pathology*
	Cores positive, Gleason score	% Cancer	Grade*	Cancer volume	Pathologic stage
Upgraded	2/12, 3+4	1%	3+4	0.5cc, 1%	pT2a
	2/12, 3+4	3%	3+3	2.9cc, 5%	pT2a
	4/12, 3+4	8%	3+4	11.7cc, 30%	pT2c
	3/12, 3+4	15%	3+4	2.2cc, 5%	pT2c
		Average (6.8%)		Average (4.3cc, 10.3%)
Elective	1/12, 3+3	8%	3+3	0.4cc, 1%	pT2c
	2/12, 3+3	6%	3+4	2.5cc, 5%	pT2c
	1/12, 3+3	10%	3+3	0.9cc, 2%	PT2a
	1/12, 3+3	2%	3+4	1.1cc, 2%	pT2c
	1/12, 3+3	5%	3+3	0.8cc, 2%	pT2c
		Average (6.2%)		Average (1.1cc, 2.4%)

^*All margins negative at RRP; no significant difference in volume between upgraded and elective groups.